Cargando…

Enhancement of cardiac lymphangiogenesis by transplantation of CD34(+)VEGFR-3(+) endothelial progenitor cells and sustained release of VEGF-C

Impairment of cardiac lymphatic vessels leads to cardiac lymphedema. Recent studies have suggested that stimulation of lymphangiogenesis may reduce cardiac lymphedema. However, effects of lymphatic endothelial progenitor cells (LEPCs) on cardiac lymphangiogenesis are poorly understood. Therefore, th...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Hai-feng, Wang, Yong-li, Tan, Yu-zhen, Wang, Hai-jie, Tao, Ping, Zhou, Pei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6778587/
https://www.ncbi.nlm.nih.gov/pubmed/31587086
http://dx.doi.org/10.1007/s00395-019-0752-z
_version_ 1783456785541103616
author Zhang, Hai-feng
Wang, Yong-li
Tan, Yu-zhen
Wang, Hai-jie
Tao, Ping
Zhou, Pei
author_facet Zhang, Hai-feng
Wang, Yong-li
Tan, Yu-zhen
Wang, Hai-jie
Tao, Ping
Zhou, Pei
author_sort Zhang, Hai-feng
collection PubMed
description Impairment of cardiac lymphatic vessels leads to cardiac lymphedema. Recent studies have suggested that stimulation of lymphangiogenesis may reduce cardiac lymphedema. However, effects of lymphatic endothelial progenitor cells (LEPCs) on cardiac lymphangiogenesis are poorly understood. Therefore, this study investigated effectiveness of LEPC transplantation and VEGF-C release with self-assembling peptide (SAP) on cardiac lymphangiogenesis after myocardial infarction (MI). CD34(+)VEGFR-3(+) EPCs isolated from rat bone marrow differentiated into lymphatic endothelial cells after VEGF-C induction. VEGF-C also stimulated the cells to incorporate into the lymphatic capillary-like structures. The functionalized SAP could adhere with the cells and released VEGF-C sustainedly. In the condition of hypoxia and serum deprivation or abdominal pouch assay, the SAP hydrogel protected the cells from apoptosis and necrosis. At 4 weeks after intramyocardial transplantation of the cells and VEGF-C loaded with SAP hydrogel in rat MI models, cardiac lymphangiogenesis was increased, cardiac edema and reverse remodeling were reduced, and cardiac function was improved significantly. Delivery with SAP hydrogel favored survival of the engrafted cells. VEGF-C released from the hydrogel promoted differentiation and incorporation of the cells as well as growth of pre-existed lymphatic vessels. Cardiac lymphangiogenesis was beneficial for elimination of the inflammatory cells in the infarcted myocardium. Moreover, angiogenesis and myocardial regeneration were enhanced after reduction of lymphedema. These results demonstrate that the combined delivery of LEPCs and VEGF-C with the functionalized SAP promotes cardiac lymphangiogenesis and repair of the infarcted myocardium effectively. This study represents a novel therapy for relieving myocardial edema in cardiovascular diseases. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00395-019-0752-z) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6778587
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-67785872019-10-17 Enhancement of cardiac lymphangiogenesis by transplantation of CD34(+)VEGFR-3(+) endothelial progenitor cells and sustained release of VEGF-C Zhang, Hai-feng Wang, Yong-li Tan, Yu-zhen Wang, Hai-jie Tao, Ping Zhou, Pei Basic Res Cardiol Original Contribution Impairment of cardiac lymphatic vessels leads to cardiac lymphedema. Recent studies have suggested that stimulation of lymphangiogenesis may reduce cardiac lymphedema. However, effects of lymphatic endothelial progenitor cells (LEPCs) on cardiac lymphangiogenesis are poorly understood. Therefore, this study investigated effectiveness of LEPC transplantation and VEGF-C release with self-assembling peptide (SAP) on cardiac lymphangiogenesis after myocardial infarction (MI). CD34(+)VEGFR-3(+) EPCs isolated from rat bone marrow differentiated into lymphatic endothelial cells after VEGF-C induction. VEGF-C also stimulated the cells to incorporate into the lymphatic capillary-like structures. The functionalized SAP could adhere with the cells and released VEGF-C sustainedly. In the condition of hypoxia and serum deprivation or abdominal pouch assay, the SAP hydrogel protected the cells from apoptosis and necrosis. At 4 weeks after intramyocardial transplantation of the cells and VEGF-C loaded with SAP hydrogel in rat MI models, cardiac lymphangiogenesis was increased, cardiac edema and reverse remodeling were reduced, and cardiac function was improved significantly. Delivery with SAP hydrogel favored survival of the engrafted cells. VEGF-C released from the hydrogel promoted differentiation and incorporation of the cells as well as growth of pre-existed lymphatic vessels. Cardiac lymphangiogenesis was beneficial for elimination of the inflammatory cells in the infarcted myocardium. Moreover, angiogenesis and myocardial regeneration were enhanced after reduction of lymphedema. These results demonstrate that the combined delivery of LEPCs and VEGF-C with the functionalized SAP promotes cardiac lymphangiogenesis and repair of the infarcted myocardium effectively. This study represents a novel therapy for relieving myocardial edema in cardiovascular diseases. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00395-019-0752-z) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2019-10-06 2019 /pmc/articles/PMC6778587/ /pubmed/31587086 http://dx.doi.org/10.1007/s00395-019-0752-z Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Contribution
Zhang, Hai-feng
Wang, Yong-li
Tan, Yu-zhen
Wang, Hai-jie
Tao, Ping
Zhou, Pei
Enhancement of cardiac lymphangiogenesis by transplantation of CD34(+)VEGFR-3(+) endothelial progenitor cells and sustained release of VEGF-C
title Enhancement of cardiac lymphangiogenesis by transplantation of CD34(+)VEGFR-3(+) endothelial progenitor cells and sustained release of VEGF-C
title_full Enhancement of cardiac lymphangiogenesis by transplantation of CD34(+)VEGFR-3(+) endothelial progenitor cells and sustained release of VEGF-C
title_fullStr Enhancement of cardiac lymphangiogenesis by transplantation of CD34(+)VEGFR-3(+) endothelial progenitor cells and sustained release of VEGF-C
title_full_unstemmed Enhancement of cardiac lymphangiogenesis by transplantation of CD34(+)VEGFR-3(+) endothelial progenitor cells and sustained release of VEGF-C
title_short Enhancement of cardiac lymphangiogenesis by transplantation of CD34(+)VEGFR-3(+) endothelial progenitor cells and sustained release of VEGF-C
title_sort enhancement of cardiac lymphangiogenesis by transplantation of cd34(+)vegfr-3(+) endothelial progenitor cells and sustained release of vegf-c
topic Original Contribution
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6778587/
https://www.ncbi.nlm.nih.gov/pubmed/31587086
http://dx.doi.org/10.1007/s00395-019-0752-z
work_keys_str_mv AT zhanghaifeng enhancementofcardiaclymphangiogenesisbytransplantationofcd34vegfr3endothelialprogenitorcellsandsustainedreleaseofvegfc
AT wangyongli enhancementofcardiaclymphangiogenesisbytransplantationofcd34vegfr3endothelialprogenitorcellsandsustainedreleaseofvegfc
AT tanyuzhen enhancementofcardiaclymphangiogenesisbytransplantationofcd34vegfr3endothelialprogenitorcellsandsustainedreleaseofvegfc
AT wanghaijie enhancementofcardiaclymphangiogenesisbytransplantationofcd34vegfr3endothelialprogenitorcellsandsustainedreleaseofvegfc
AT taoping enhancementofcardiaclymphangiogenesisbytransplantationofcd34vegfr3endothelialprogenitorcellsandsustainedreleaseofvegfc
AT zhoupei enhancementofcardiaclymphangiogenesisbytransplantationofcd34vegfr3endothelialprogenitorcellsandsustainedreleaseofvegfc